The GSK UK Group has informed GlaxoSmithKline Consumer Nigeria PLC of its strategic intent to cease commercialization of its prescription medicines and vaccines in Nigeria.
Trending
- Lagos raises alarm over threats of flash floods
- Rising costs of farming inputs hinder Niger State farmers
- AfDB, partners to mobilize $15bn for ECOWAS Lagos-Abidjan Highway project – Adesina
- Nigeria seeks another $500m World Bank loan to boost basic education
- Meta unveils AI model to reduce human role in AI development
- Nigeria has highest number of people living without electricity globally – AfDB
- Boko Haram releases shocking video of beheadings in northeast Nigeria
- [EXPLAINER] If you have HIV, should you be on medication for life?
